Literature DB >> 4244917

Red cell enzymes in trisomy 21.

S N Pantelakis, A G Karaklis, D Alexiou, E Vardas, T Valaes.   

Abstract

Mesh：

Substances：

Year:  1970        PMID： 4244917      PMCID： PMC1706523     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  32 in total

1.  HEMOLYTIC EFFECT OF PRIMAQUINE. XVII. HEXOKINASE ACTIVITY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT AND NORMAL ERYTHROCYTES.

Authors:  G J BREWER; R D POWELL; S H SWANSON; A S ALVING
Journal:  J Lab Clin Med       Date:  1964-10

2.  The leucocyte alkaline phosphatase in mongolism.

Authors:  S TRUBOWITZ; D KIRMAN; B MASEK
Journal:  Lancet       Date:  1962-09-08       Impact factor: 79.321

3.  Types of thalassaemia-trait carriers as revealed by a study of their incidence in Greece.

Authors:  B MALAMOS; P FESSAS; G STAMATOYANNOPOULOS
Journal:  Br J Haematol       Date:  1962-01       Impact factor: 6.998

4.  A comparative study of hexokinase from yeast and animal tissues.

Authors:  M W SLEIN; G T CORI; C F CORI
Journal:  J Biol Chem       Date:  1950-10       Impact factor: 5.157

5.  [Enzymes in trisomy-21 (mongolism)].

Authors:  R Schuppisser; E Joss; R Richterich
Journal:  Schweiz Med Wochenschr       Date:  1967-11-18

6.  Biochemical differentiation of trisomic Down's syndrome (mongolism) from that due to translocation.

Authors:  F Rosner; B H Ong; R S Paine; D Mahanand
Journal:  N Engl J Med       Date:  1965-12-16       Impact factor: 91.245

7.  Genetically determined electrophoretic variations of human phosphogluconate dehydrogenase.

Authors:  N D Carter; R A Fildes; L I Fitch; C W Parr
Journal:  Acta Genet Stat Med       Date:  1968

8.  Enzymes in Down's syndrome.

Authors:  H Bartels; K Kruse; M Tolksdorf
Journal:  Lancet       Date:  1968-04-13       Impact factor: 79.321

Review 9.  [On the problem of assigning genes to definite human autosomes with the aid of chromosome aberrations].

Authors:  K Bender; H Ritter; U Wolf
Journal:  Humangenetik       Date:  1967

10.  A ring D chromosome and anomalous inheritance of haptoglobin type.

Authors:  P S Gerald; S Warner; J D Singer; P A Corcoran; I Umansky
Journal:  J Pediatr       Date:  1967-02       Impact factor: 4.406
View more
  7 in total

1.  Evidence for the lack of feedback regulation of gene activity and for the absence of subunit exchange between lactate dehydrogenase tetramers in vivo.

Authors:  B Nadal-Ginard
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

2.  Gene dosage: evidence for assignment of erythrocyte acid phosphatase locus to chromosome 2.

Authors:  R E Magenis; R D Koler; E Lovrien; R H Bigley; M C DuVal; K M Overton
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

3.  Regional assignment of human liver-type 6-phosphofructokinase to chromosome 21q22.3 by using somatic cell hybrids and a monoclonal anti-L antibody.

Authors:  M Van Keuren; H Drabkin; I Hart; D Harker; D Patterson; S Vora
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

4.  Phosphofructokinase and chromosome 21.

Authors:  R B Layzer; C J Epstein
Journal:  Am J Hum Genet       Date:  1972-09       Impact factor: 11.025

5.  The levels of superoxide dismutase, catalase, and carbonic anhydrase in erythrocytes of patients with Down's syndrome.

Authors:  H Ohno; S Lizuka; T Kondo; K Yamamura; C Sekiya; N Taniguchi
Journal:  Klin Wochenschr       Date:  1984-03-15

6.  Assignment of the human gene for liver-type 6-phosphofructokinase isozyme (PFKL) to chromosome 21 by using somatic cell hybrids and monoclonal anti-L antibody.

Authors:  S Vora; U Francke
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

7.  Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation.

Authors:  O Elroy-Stein; Y Bernstein; Y Groner
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.